Patients with severe asthma who are typically underrepresented in clinical studies experienced improved outcomes with ...

Nebulized treprostinil (Tyvaso) reduced lung function decline from idiopathic pulmonary fibrosis (IPF) in the pivotal TETON-1 ...

Two phase 3, randomized trials of inhaled treprostinil for idiopathic pulmonary fibrosis (IPF) were conducted on the basis of preclinical and clinical evidence of an antifibrotic mechanism.

Among hospitalized adults with acute exacerbation of COPD, pegtarazimod improved oxygen utilization and inflammatory ...

Spiriva is not a steroid. Learn how this bronchodilator differs from corticosteroids, how it treats asthma and COPD, and what ...

Acquisition includes LAM-001, an inhaled formulation of rapamycin for multiple pulmonary diseases, including pulmonary hypertension associated ...

mPublic Health and Preventive Medicine, Monash University, Melbourne, VIC, Australia nVictorian Heart Hospital, Monash Health and Monash Cardiovascular Research Centre, Monash University, Melbourne, ...

We’re conducting a research study and recruiting people with chronic obstructive pulmonary disease (COPD), including emphysema and chronic bronchitis, who are interested in information and support to ...

Presented during the Breaking News: Clinical Trial Results in Pulmonary Medicine Advance Outcomes session, TETON-1 evaluated inhaled treprostinil in patients with idiopathic pulmonary fibrosis, a ...

New research presented at this year's European Congress on Obesity in Istanbul, Turkey (12-15 May) shows the use of the new ...

cSt George's School of Health and Medical Sciences, City St George's University of London, London, UK dPublic Health Research Institute, St George's School of Health and Medical Sciences, City St ...

What is Breztri?: A triple therapy inhaler combining three medications, prescribed for COPD patients not improving on double therapy. How it helps: Used twice daily, Breztri can reduce exacerbations ...